BRAP expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.366200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.212800E-01
Normal-vs-Stage2
5.671400E-01
Normal-vs-Stage3
1.726800E-01
Normal-vs-Stage4
9.499600E-01
Stage1-vs-Stage2
4.990500E-02
Stage1-vs-Stage3
7.749600E-02
Stage1-vs-Stage4
5.203400E-01
Stage2-vs-Stage3
1.891560E-01
Stage2-vs-Stage4
4.709200E-01
Stage3-vs-Stage4
1.598810E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.695400E-01
Normal-vs-AfricanAmerican
7.243000E-01
Normal-vs-Asian
1.477780E-01
Caucasian-vs-AfricanAmerican
8.603200E-01
Caucasian-vs-Asian
4.226400E-02
AfricanAmerican-vs-Asian
3.270600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.548400E-01
Normal-vs-Female
5.910800E-01
Male-vs-Female
2.123000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.732200E-01
Normal-vs-Age(41-60Yrs)
9.040800E-01
Normal-vs-Age(61-80Yrs)
7.500200E-01
Normal-vs-Age(81-100Yrs)
6.425800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.950200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.278000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.460400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.890500E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.878400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.736600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.217600E-01
Normal-vs-Daily Drinker
7.174400E-01
Normal-vs-Weekly Drinker
5.635800E-01
Normal-vs-Occasional Drinker
7.724800E-01
Normal-vs-Social Drinker
8.993200E-01
Non Drinker-vs-Daily Drinker
1.176190E-01
Non Drinker-vs-Weekly Drinker
4.854000E-01
Non Drinker-vs-Occasional Drinker
7.843600E-03
Non Drinker-vs-Social Drinker
7.030100E-02
Daily Drinker-vs-Weekly Drinker
5.985200E-01
Daily Drinker-vs-Occasional Drinker
2.294400E-01
Daily Drinker-vs-Social Drinker
6.961000E-01
Weekly Drinker-vs-Occasional Drinker
1.547990E-01
Weekly Drinker-vs-Social Drinker
4.334600E-01
Occasional Drinker-vs-Social Drinker
4.718800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.206400E-01
Normal-vs-Grade 2
6.711600E-01
Normal-vs-Grade 3
6.636600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.393400E-01
Grade 1-vs-Grade 3
2.709000E-01
Grade 1-vs-Grade 4
4.206400E-01
Grade 2-vs-Grade 3
8.548000E-01
Grade 2-vs-Grade 4
6.711600E-01
Grade 3-vs-Grade 4
6.636600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.960600E-01
Normal-vs-NonDiabetic
8.499200E-01
Diabetic-vs-NonDiabetic
4.329800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.067420E-01
Normal-vs-NoPancreatitis
8.577400E-01
Pancreatitis-vs-NoPancreatitis
3.107900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.822200E-01
Normal-vs-N1
5.994000E-01
N0-vs-N1
2.938200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.302800E-01
Normal-vs-TP53-NonMutant
7.770200E-01
TP53-Mutant-vs-TP53-NonMutant
9.436100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
